Director Shareholding

| Filed in:
Tate & Lyle PLC (the Company) was informed on 5 November 2004 that the following share transactions were completed by Directors of the Company: On 5 November 2004, Mr Simon Gifford, an Executive Director of the Company, sold 6,000 ordinary shares of the Company at 451 pence per share. Mr Gifford now has an interest in 75,014 ordinary shares in the Company. On 5 November 2004, Mr Stanley Musesengwa, an Executive Director of the Company, exercised the following options over ordinary shares of the Company under the Tate & Lyle 1992 Executive Share Option Scheme: 13,000 options at 425 pence per share 26,785 options at 336 pence per share 70,437 options at 274 pence per share He subsequently sold 89,253 ordinary shares at 456.50 pence per share to pay the subscription price, tax and National Insurance, and retained 20,969 ordinary shares. Following this transaction, Mr Musesengwa now has an interest in 26,969 ordinary shares in the Company.

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit or follow Tate & Lyle on Twitter or Linkedin.